08:22 AM EDT, 10/28/2024 (MT Newswires) -- ImmunoPrecise Antibodies ( IPA ) said Monday that it has made a 'significant contribution' to an anti-aging study led by scientists at the Mayo Clinic.

The biotech firm said the study used its proprietary rabbit B Cell Select platform to isolate and generate antibodies that target phosphorylated ubiquitin, which is an indicator of mitochondrial damage.

"This study advances our understanding of how aging impacts mitochondrial health, a crucial factor in neurodegenerative diseases like Parkinson's and Alzheimer's," the company said.

Price: 0.6497, Change: -0.03, Percent Change: -4.19